Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Revenues:
Total revenues		$ 132,645	$ 113,765
Operating expenses:
Cost of revenues	[1]	40,251	31,937
Research and development	[1]	18,186	20,736
Sales and marketing	[1]	45,722	42,678
Editorial	[1]	17,869	15,956
General and administrative	[1]	65,550	77,801
Amortization of intangible assets	[1]	11,509	10,451
Impairment of goodwill and other long-lived assets	[1]	32,064
Transaction (gains) costs, net	[1]	(767)	2,395
Total operating expenses	[1]	230,384	201,954
Operating loss		(97,739)	(88,189)
Interest expense, net		29,940	95,741
Change in fair value of financial instruments		(15,983)	(12,747)
Gain on PPP loan upon extinguishment			(7,667)
Loss on debt extinguishment, net			45,250
Loss on settlement		3,474	11,700
Other expense, net		68	1,045
Net loss before income taxes		(115,238)	(221,511)
Provision (benefit) from income taxes		223	(3,254)
Net loss		(115,461)	(218,257)
Other comprehensive income (loss)		163	(154)
Total comprehensive loss		(115,298)	(218,411)
Net loss		(115,461)	(218,257)
Deemed dividend			(26,570)
Net loss used to compute basic loss per share		(115,461)	(244,827)
Net loss used to compute diluted loss per share		$ (115,461)	$ (244,827)
Earnings (loss) per share attributable to common shareholders:
Basic		$ (0.88)	$ (3.68)
Diluted		$ (0.88)	$ (3.68)
Weighted average shares used in computing earnings (loss) per share attributable to common shareholders:
Basic		131,400,109	66,513,704
Diluted		131,400,109	66,513,704
Subscription
Revenues:
Total revenues		$ 119,082	$ 100,522
Advisory, advertising, and other
Revenues:
Total revenues		$ 13,563	$ 13,243

[1] (1) Amounts include stock-based compensation expenses, as follows:       Years Ended December 31,       2023     2022   Cost of revenues   $ 283     $ 81   Research and development     1,384       1,007   Sales and marketing     2,057       762   Editorial     400       603   General and administrative     22,933       35,594